Metraipolis › archive › dc_eb03aa87fbd7

Trends in paediatric antiseizure-medication use and costs in France, 2014-2023: a nationwide population-based analysis — Europe PMC PMID:41675438

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41675438
DOI: 10.1016/j.lanepe.2026.101594
License (as archived): solo-consultazione
Archived: 2026-10-08T12:20:58.914Z
SHA-256 of the archived text: 83484816e125bee72ef53025689b81d7ffe83c74c1de9e499c30a3c425b11477
Stable URL of this page: https://metraipolis.com/documento/dc_eb03aa87fbd7

How to cite

Trends in paediatric antiseizure-medication use and costs in France, 2014-2023: a nationwide population-based analysis — Europe PMC PMID:41675438 — Europe PMC (en), https://europepmc.org/article/MED/41675438 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb03aa87fbd7 (Metraipolis archive dc_eb03aa87fbd7, sha256 83484816e125bee72ef53025689b81d7ffe83c74c1de9e499c30a3c425b11477)

BibTeX

@misc{dceb03aa87fbd7,
  title = {Trends in paediatric antiseizure-medication use and costs in France, 2014-2023: a nationwide population-based analysis — Europe PMC PMID:41675438},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41675438},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb03aa87fbd7; sha256 83484816e125bee72ef53025689b81d7ffe83c74c1de9e499c30a3c425b11477},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41675438. Agents can read the archived copy with the MCP tool read_document.